MMP8 antibody - Carboxyterminal end (ab38990)

Product Name 

MMP8 antibody - Carboxyterminal end

Product type 

Primary antibodies

Description 

Rabbit polyclonal to MMP8 - Carboxyterminal end

Immunogen 

Synthetic peptide based on the carboxy terminal end of human MMP8.

(Peptide available as ab41065.)

Reacts with 
(species key)

Hu

Specificity 

Ab38990 recognises MMP8 in its carboxiterminal region. It does not recognize the smallest active form of MMP8, since the hemopexin domain is cleaved to produce this form. It also does not cross react with the other MMP family members.

We have a range of domain specific antibodies for this target. For a full list please see all MMP8 antibodies

Tested applications 
(see key)

WB

Abreviews 

Customer reviews (see key)

Read about Abreviews

Application notes 
(see key)

Recommended dilutions
WB: Recommended starting dilution of 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 when using chemiluminescent substrates. Predicted molecular weight: 53 kDa. When used against the reduced protein, ab38990 identifies bands at 64 kDa, 58 kDa, and a series of further cleaved active forms. Note: MMP8 levels in quiescent cells and tissues are minimal and mitogen stimulation or protein concentration is often needed to visualize the bands. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Cellular localization 

Extracellular space and stored in intracellular granules.

Research areas 

Cancer >> Tumor biomarkers >> Enzymes >> MMPs
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Metalloprotease >> MMPs
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> MMPs
Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> MMP

Relevance 

Matrix Metalloproteinase 8 (MMP8) is also known as neutrophil collagenase and collagenase 2. MMP8 degrades fibrillar collagens types I, II, III, aggrecan, serpins and alpha 2 macroglobulin. All collagenases cleave fibrillar collagens at one specific site resulting in generation of N terminal three quarter and C terminal one quarter fragments, which then denature to gelatin at body temperature. The substrate specificity of collagenases is variable: MMP1 degrades type III collagen more efficiently than type I or type II collagen, whereas MMP8 is more potent in degrading type I collagen than type III or type II collagen. MMP13, in turn degrades type II collagen 6 fold more efficiently than type I and type II collagens and displays almost 50 fold stronger gelatinolytic activity than MMP1 and MMP8. MMP8 is very similar to MMP1, sharing 57 % amino acid identity. Most cell types do not produce MMP8. Until recently, it was thought that MMP8 was produced exclusively by neutrophils, but it has also been detected in other cell types including arthritic chondrocytes and gingival fibroblasts. The human MMP8 gene has the chromosomal location of 11q22.2-22.3. MMP8 is heavily glycosylated, and the zymogen has a mass of 85 Kd. The zymogen is quickly activated to the 64 Kd form, and this breaks down to a cascade of active forms.

Database links 

Raised in 

Rabbit

Clonality 

Polyclonal

Isotype 

IgG

Purity 

Immunogen affinity purified

Storage buffer 

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Material safety datasheets (MSDS) for this product:
Glycerol MSDS
Sodium Azide MSDS

Form 

Liquid

Concentration 

1.000 mg/ml

Storage instructions 

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Customer reviews (feedback) regarding MMP8 antibody - Carboxyterminal end

Customer FAQs regarding MMP8 antibody - Carboxyterminal end

Protocols for MMP8 antibody - Carboxyterminal end

Price and availability of products related to MMP8 antibody - Carboxyterminal end

MMP8 antibody - Carboxyterminal end - related products: